🇺🇸 FDA
Patent

US 10280197

Discovery of the first selective C5A receptor 2 (C5L2/C5AR2) ligands

granted A61KA61K38/00

Quick answer

US patent 10280197 (Discovery of the first selective C5A receptor 2 (C5L2/C5AR2) ligands) held by The Regents of the University of California expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00